SOD1, an unexpected novel target for cancer therapy

Genes and Cancer

Volumn 5, Issue 1-2, 2015, Pages 15-21

  Papa, Luena ^a   Manfredi, Giovanni ^b   Germain, Doris ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cancer; FALS; SIRT3; SOD1; SOD2

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE; SIRTUIN 3;

AMYOTROPHIC LATERAL SCLEROSIS; BREAST CANCER; CANCER CELL; CANCER THERAPY; CELL DEATH; CELL NUCLEUS; CYTOPLASM; ENZYME ACTIVITY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LUNG CANCER; MITOCHONDRION; NONHUMAN; ONCOGENE RAS; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; UNFOLDED PROTEIN RESPONSE;

EID: 84919352238     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Herrmann JM & Riemer J. The intermembrane space of mitochondria. Antioxid Redox Signal 2010; 13(9):1341-1358.
2. Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 2991; 362(6415):59-62.
3. Ilieva H, Polymenidou M, & Cleveland DW Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009; 187(6):761-772.
4. Hervias I, Beal MF, & Manfredi G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve 2006; 33(5):598-608.
5. Shi P, Gal J, Kwinter DM, Liu X, & Zhu H. Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim Biophys Acta.2009; 1802(1):45-51.
6. Boillee S, Vande Velde C, & Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006; 52(1):39-59.
7. Nagai M, Re DB, Nagata T, et al. (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10(5):615-622.
8. Yamanaka K, Chun SJ, Boillee S, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008; 11(3):251-253.
9. Haidet-Phillips AM, Hester ME, Miranda CJ, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nature biotechnology 2011; 29(9):824-828.
10. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994; 264(5166):1772-1775.
11. Kikuchi H, Almer G, Yamashita S et al. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc Natl Acad Sci U S A 2006; 103(15):6025-6030.
12. Higgins CM, Jung C, & Xu Z ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci 2003; 4(1):16.
13. Couillard-Despres S, et al. (1998) Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proceedings of the National Academy of Sciences of the United States of America 95(16):9626-9630.
14. Lobsiger CS, Zhu Q, Wong PC, Price DL, Cleveland DW, Julien JP. Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc Natl Acad Sci U S A. 2009; 95(16):9626-30.
15. Breckenridge DG, Germain M, Mathai JP, Nguyen M, & Shore GC. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 2003; 22(53):8608-8618.
16. Kabashi E & Durham HD Failure of protein quality control in amyotrophic lateral sclerosis. Biochim Biophys Acta 2006; 1762(11-12):1038-1050.
17. Yoshihara T, Ishigaki S, Yamamoto M, et al. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 2002; 80(1):158-167.
18. Raoul C, Estévez AG, Nishimune H, et al. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 2002; 35(6):1067-1083.
19. Beckman JS, Estevez AG, Crow JP, & Barbeito L Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci 2001; 24(11 Suppl):S15-20.
20. Shaw PJ & Eggett CJ Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol 247 Suppl 2000; 1:I17-27.
21. Maragakis NJ, Dietrich J, Wong V et al. Glutamate transporter expression and function in human glial progenitors. Glia 2004; 45(2):133-143.
22. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 2006; 9(1):108-118.
23. Vande Velde C, Miller TM, Cashman NR, & Cleveland DW Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci U S A 2008; 105(10):4022-4027.
24. Pedrini S, Sau D, Guareschi S, et al. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum Mol Genet 2010; 19(15):2974-2986.
25. Israelson A, Arbel N, Da Cruz S, et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. 2010; Neuron 67(4):575-587.
26. Vijayvergiya C, Beal MF, Buck J, & Manfredi G Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci 2005; 25(10):2463-2470.
27. Kawamata H & Manfredi G Different regulation of wildtype and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria. 2008; Hum Mol Genet 17(21):3303-3317.
28. Ferri A, Cozzolino M, Crosio C, et al. Familial ALSsuperoxide dismutases associate with mitochondria and shift their redox potentials. Proc Natl Acad Sci U S A 2006; 103(37):13860-13865.
29. Magrané J, Hervias I, Henning MS, Damiano M, Kawamata H, Manfredi G. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum Mol Genet 2009; 18(23):4552-4564.
30. Cozzolino M, Pesaresi MG, Amori I, et al. Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity. Antioxid Redox Signal 2009; 11(7):1547-1558.
31. Igoudjil A, Magrané J, Fischer LR, et al. In vivo pathogenic role of mutant SOD1 localized in the mitochondrial intermembrane space. J Neurosci 2011; 31(44):15826-15837.
32. Fischer LR, Igoudjil A, Magrané J, et al. SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse. Brain : a journal of neurology 2011; 134(Pt 1):196-209.
33. Schumacker PT A tumor suppressor SIRTainty. Cancer Cell 2010; 17(1):5-6.
34. Alhazzazi TY, Kamarajan P, Verdin E, & Kapila YL SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta 2011; 1816(1):80-88.
35. Bell EL & Guarente L The SirT3 divining rod points to oxidative stress. Mol Cell 2011; 42(5):561-568.
36. Finley LW, Carracedo A, Lee J, et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 2011; 19(3):416-428.
37. Bell EL, Emerling BM, Ricoult SJ, & Guarente L SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene 2011; 30(26):2986-2996.
38. Tao R, Coleman MC, Pennington JD, et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 2010; 40(6):893-904.
39. Trachootham D, Alexandre J, & Huang P Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8(7):579-591.
40. Lemarie A & Grimm S Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer? Oncogene 30(38):3985-4003.
41. Langer T, Kaser M, Klanner C, & Leonhard K AAA proteases of mitochondria: quality control of membrane proteins and regulatory functions during mitochondrial biogenesis. Biochem Soc Trans 2001; 29(Pt 4):431-436.
42. Somwar R, Erdjument-Bromage H, Larsson E, et al. Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines. Proc Natl Acad Sci U S A 2011; 108(39):16375-16380.
43. Huang P, Feng L, Oldham EA, Keating MJ, & Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407(6802):390-395.
44. Papa L, Hahn, M., Marsh, E.L., Evans, B.S., Germain, D. SOD2 to SOD1 switch in breast cancer. Journal of Biological Chemistry In Press.
45. Glasauer A, Sena LA, Diebold LP, Mazar AP, & Chandel NS Targeting SOD1 reduces experimental non-small-cell lung cancer. J Clin Invest.2013; 124(1):117-28.
46. Finley LW, Carracedo A, Lee J, et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 2011; 19(3):416-428.
47. Rao AK, Ziegler YS, McLeod IX, Yates JR, & Nardulli AM Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells. Mol Endocrinol 2008; 22(5):1113-1124.
48. Baker BM, Nargund AM, Sun T, & Haynes CM Protective coupling of mitochondrial function and protein synthesis via the eIF2alpha kinase GCN-2. PLoS genetics 2012; 8(6):e1002760.
49. Benedetti C, Haynes CM, Yang Y, Harding HP, & Ron D Ubiquitin-like protein 5 positively regulates chaperone gene expression in the mitochondrial unfolded protein response. Genetics 2006; 174(1):229-239.
50. Haynes CM, Petrova K, Benedetti C, Yang Y, & Ron D ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Dev Cell 2007; 13(4):467-480.
51. Papa L & Germain D. SirT3 regulates a novel arm of the mitochondrial unfolded protein response. Mol Cell Biol. 2014; 34(4):699-710.
52. Papa L & Germain D Estrogen receptor mediates a distinct mitochondrial unfolded protein response. J Cell Sci 2011; 124(Pt 9):1396-1402.